iBio

iBio is enabling the next generation of biologics through the FastPharming® system to produce high-quality, environmentally friendly recombinant proteins. Using our Nicotiana benthamiana plants, which can efficiently express a variety of proteins, we provide these capabilities to our customers through a range of contract development and manufacturing services, and deploy them into our own pipeline of therapeutics, vaccines, and research and bioprocessing applications. Additionally, through our new Glycaneering™ development service, we can achieve better control over protein glycosylation, including the ability to remove fucose to create more effective monoclonal antibody therapies.